Xenon Pharmaceuticals Q1 Loss Widens-July 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Xenon Pharmaceuticals Q1 Loss Widens

May 7, 2026 2:49 PM

05:28 PM EDT, 05/07/2026 (MT Newswires) -- Xenon Pharmaceuticals ( XENE ) reported late Thursday a Q1 net loss of $1.17 per diluted share, compared with a loss of $0.83 a year earlier.

Based on current operating plans, Xenon said it expects having sufficient cash to fund operations into 2029.

Previous page： BioNTech Q4 Earnings, Revenue Fall; Sets 2024 Revenue Guidance -- Shares Drop Premarket Next page： Tencent Music beats quarterly revenue estimates (March 19)

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BioNTech Q4 Earnings, Revenue Fall; Sets 2024 Revenue Guidance -- Shares Drop Premarket

Mar 20, 2024

07:01 AM EDT, 03/20/2024 (MT Newswires) -- BioNTech (BNTX) reported Q4 earnings Wednesday of 1.90 euro ($2.06) per diluted share, down from 9.26 euros a year earlier. Analysts polled by Capital IQ expected 2.65 euros. Revenue for the quarter ended Dec. 31 was 1.48 billion euros, down from 4.28 billion euros a year earlier. Analysts surveyed by Capital IQ expected...

Tencent Music beats quarterly revenue estimates (March 19)

Mar 20, 2024

HONG KONG, March 19 (Reuters) - China's Tencent Music Entertainment Group ( TME ) beat fourth-quarter revenue estimates on Tuesday, driven by growth in paid subscription on its Spotify ( SPOT )-like music streaming platform. The audio entertainment platform reported revenue of 6.89 billion yuan ($957.06 million) for the quarter, marking a 7.2% decline as compared to the same period...

Bristol Myers liver cancer treatment meets main goal of late-stage study

Mar 20, 2024

March 20 (Reuters) - Bristol Myers Squibb ( BMY ) said on Wednesday a combination of its drugs, Opdivo and Yervoy, met the main goal of a late-stage study evaluating it as a first-line treatment for a type of liver cancer. (Reporting by Puyaan Singh) ...

General Mills posts smaller-than-expected drop in quarterly sales

Mar 20, 2024

March 20 (Reuters) - Cheerios maker General Mills ( GIS ) posted a smaller-than-expected drop in quarterly sales on Wednesday, backed by higher prices for its breakfast cereals, snack bars and pet food products that helped cushion a blow from slowing demand. The Cheerios cereal maker's net sales dropped about 1% to $5.1 billion in the third quarter, compared with...